Barbara Messore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Barbara Messore has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Cinzia Ferrero
AOU Città della Salute e della Scienza di Torino, Regina Margherita Children's Hospital - Pediatric Pulmonology/Pediatric CF Centre, Torino, Italy
2 shared publications- Adelina Amorim
Pulmonology Department, Unidade de Saúde Local S.João, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal
1 shared publication Alessio Mattei
SCU Pneumologia, Città della Salute e della Scienza-Presidio Molinette, Turin (TO), Italy
1 shared publicationAlistair Duff
Leeds Children's Hospital, Leeds, United Kingdom
1 shared publicationAndrea Gramegna
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
1 shared publication- Andrea Gramegna
Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 6 April 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 241, 108076
Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective
- 6 April 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 241, 108076
Open AccessGuidance for chest-CT in children and adults with cystic fibrosis: A European perspective
- 8 November 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (2) , 306-313
Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis
- 8 November 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (2) , 306-313
Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64) , 3425
Non Invasive Ventilation in adult CF patients: a single centre experience in last two decades
In Cystic Fibrosis (CF) chronic progressive respiratory disease results in acute and chronic respiratory failure. Aims and Objectives: To evaluate practice of Non Invasive Ventilation (NIV) in adults with CF. Methods: Retrospective observational analysis of clinical records on the use of NIV at the Torino Adult CF Centre since 1996. Data were collected at the beginning of NIV, after 6 months and 1 - 3 years (yrs) of chronic use. Results: 22 pts were adapted to NIV. Clinical features at the beginning (mean, range): age 34.2 yrs (22-59), BMI 19.99 (15.7-25.7), ppFEV1 31.3 (15-46), arterial pH 7.39 (7.30-7.44) and PaCO2 48.75 mmHg (33-80); 21 (95.5%) pancreatic insufficient. In the year before NIV 3.76 IV antibiotic (atb) cycles/patient (pt). The main indication for NIV was respiratory exacerbation with acute respiratory failure (77.3%). PSV was the most common mode of ventilation (86.4%.) At 6 months mean ppFEV1 30.05 (15-44), mean PaCO2 48.67 mmHg (36.6-63), mean BMI 20.26 Kg/m2 (16.1-26). At 1 yr mean ppFEV1 32.4 (18-49), mean BMI 20.38 (15.7-26.5), mean PaCO2 45.32 mmHg (32.5-64), 3.54 cycles IV atb/yr/pt. At 3 yrs 6 pts still on NIV: mean ppFEV1 32.5 (24-40), mean BMI 19.58 (16.9-21.45), mean PaCO2 44.68 mmHg (35.4-69), 3.33 cycles IV atb/yr/pt. Conclusions: In CF adults with advanced disease chronic NIV is a good option which can slow the progression of respiratory failure and may contribute to stabilize clinical conditions, beyond its recognized role as a bridge to transplant and as a support to airway clearance.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64) , 3425
Non Invasive Ventilation in adult CF patients: a single centre experience in last two decades
In Cystic Fibrosis (CF) chronic progressive respiratory disease results in acute and chronic respiratory failure. Aims and Objectives: To evaluate practice of Non Invasive Ventilation (NIV) in adults with CF. Methods: Retrospective observational analysis of clinical records on the use of NIV at the Torino Adult CF Centre since 1996. Data were collected at the beginning of NIV, after 6 months and 1 - 3 years (yrs) of chronic use. Results: 22 pts were adapted to NIV. Clinical features at the beginning (mean, range): age 34.2 yrs (22-59), BMI 19.99 (15.7-25.7), ppFEV1 31.3 (15-46), arterial pH 7.39 (7.30-7.44) and PaCO2 48.75 mmHg (33-80); 21 (95.5%) pancreatic insufficient. In the year before NIV 3.76 IV antibiotic (atb) cycles/patient (pt). The main indication for NIV was respiratory exacerbation with acute respiratory failure (77.3%). PSV was the most common mode of ventilation (86.4%.) At 6 months mean ppFEV1 30.05 (15-44), mean PaCO2 48.67 mmHg (36.6-63), mean BMI 20.26 Kg/m2 (16.1-26). At 1 yr mean ppFEV1 32.4 (18-49), mean BMI 20.38 (15.7-26.5), mean PaCO2 45.32 mmHg (32.5-64), 3.54 cycles IV atb/yr/pt. At 3 yrs 6 pts still on NIV: mean ppFEV1 32.5 (24-40), mean BMI 19.58 (16.9-21.45), mean PaCO2 44.68 mmHg (35.4-69), 3.33 cycles IV atb/yr/pt. Conclusions: In CF adults with advanced disease chronic NIV is a good option which can slow the progression of respiratory failure and may contribute to stabilize clinical conditions, beyond its recognized role as a bridge to transplant and as a support to airway clearance.